Ryan C. Massa
Oncology
3400 Civic Center Boulevard
West Pavilion, 2nd Floor
Philadelphia, PA 19104
West Pavilion, 2nd Floor
Philadelphia, PA 19104
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Lead-in therapy targeting PD1 and/or LAG3 imposes distinct immune phenotypes in first-line treatment of metastatic melanoma.
Journal: medRxiv : the preprint server for health sciences
Published: November 24, 2025
Implementation of DPYD and UGT1A1 Testing in Patients With GI Cancer: A Prospective, Nonrandomized Clinical Trial.
Journal: JCO precision oncology
Published: August 07, 2025
Blockade of LAG-3 and PD-1 leads to co-expression of cytotoxic and exhaustion gene modules in CD8+ T cells to promote antitumor immunity.
Journal: Cell
Published: February 09, 2023
Challenges in the Management of Patients With HER2-Amplified Colorectal Cancer.
Journal: JCO oncology practice
Published: July 05, 2022
Niraparib plus nivolumab or niraparib plus ipilimumab in patients with platinum-sensitive advanced pancreatic cancer: a randomised, phase 1b/2 trial.
Journal: The Lancet. Oncology
Published: March 22, 2022
Phase I Trial of Regorafenib, Hydroxychloroquine, and Entinostat in Metastatic Colorectal Cancer.
Journal: The oncologist
Published: March 01, 2022
Implementing Pharmacogenetic Testing in Gastrointestinal Cancers (IMPACT-GI): Study Protocol for a Pragmatic Implementation Trial for Establishing DPYD and UGT1A1 Screening to Guide Chemotherapy Dosing.
Journal: Frontiers in oncology
Published: January 21, 2022
Evolving standards of care for neoadjuvant and adjuvant therapy in esophageal, gastroesophageal junction, and gastric cncer.
Journal: Clinical advances in hematology & oncology : H&O
Published: December 20, 2021
CD8 T cells compensate for impaired humoral immunity in COVID-19 patients with hematologic cancer.
Journal: Research square
Published: February 10, 2021
CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer.
Journal: Nature medicine
Published: January 27, 2021
DPYD and UGT1A1 Pharmacogenetic Testing in Patients with Gastrointestinal Malignancies: An Overview of the Evidence and Considerations for Clinical Implementation.
Journal: Pharmacotherapy
Published: September 28, 2020
Last Updated: 09/26/2026